1,2-Dibromocyclopent-1-ene

Catalog No.: 
ACUGSB930
CAS No.: 
75415-78-0
Molecular Formula: 
C5H6Br2
Molecular Weight: 
225.91
1,2-Dibromocyclopent-1-ene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$75.00In stockInquiry
5g96%$248.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,2-Dibromocyclopent-1-ene
IUPAC Name1,2-dibromocyclopent-1-ene
MDL No.MFCD00010246
Molecular FormulaC5H6Br2
Molecular Weight225.91
SMILESBrC1=C(Br)CCC1
InChI KeyPNWFXPGGROADNS-UHFFFAOYSA-N
Synonym1,2-Dibromocyclopentene | PNWFXPGGROADNS-UHFFFAOYSA-N | SY065374 | DTXSID50403305 | CS-17357 | CS-W013034 | FT-0641563 | AKOS015834957 | 1,2-Dibromo-1-cyclopentene | 1,2-dibromocyclopent-1-ene | MFCD00010246 | 1,1-Cyclohexane diacetic acid(CDA) | 1,2-Dibromocyclopentene, 97% | SCH
CAS No.75415-78-0
PubChem CID4438528

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H227-H302+H332-H318
Precautionary Statement(s)
P210-P261-P264-P270-P271-P280-P301+P312+P330-P305+P351+P338+P310-P370+P378-P403+P235-P501

Synthetic Route by SureRoute

1. ACUGSB930 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUGSB930 route product structure diagram
    ACUGSB93075415-78-0In Stock
Inquiry

2. ACUGSB930 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUGSB930 route product structure diagram
    ACUGSB93075415-78-0In Stock
Inquiry

3. ACUGSB930 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUGSB930 route product structure diagram
    ACUGSB93075415-78-0In Stock
Inquiry

Comments (0)